证券之星消息，1月23日半导体板块较上一交易日上涨0.02%，臻镭科技领涨。当日上证指数报收于 4136.16，上涨0.33%。深证成指报收于14439.66，上涨0.79%。半导体板块个股涨跌见下表： 从资金流向上来看，当日半导体板块主力资金净流出90.34亿元，游资资金净流入19.21亿元，散户资金净 流入71.13亿元。半导体板块个股资金流向见下表： | 代码 | 名称 | 主力净流入 (元) | | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 688270 | | | 5.91 Z | 9.58% | -4.03 Z | -6.54% | -1.88 Z- | -3.05% | | 002049 | 紫光国微 | | 3.13 乙 | 6.91% | -1.79亿 | -3.94% | -1.35 Z | -2.97% | | 600745 | 闻泰科技 | | 2.71亿 | 8.72% | -1.52亿 | -4.90% | -1. ...

1 大大基金 | 链接您与财富 图看懂 公募2025持仓变迁 从公募2025年季度持仓数据来看,宁德时代全年稳居 重仓股首位,中际旭创、新易盛等科技股在下半年排名 显著上升。行业配置上,全年公募基金行业配置明显转 向,从传统消费、金融板块切换至科技成长板块。 | | 202501 | 202502 | 2025Q3 | 202504 | | --- | --- | --- | --- | --- | | 1 | 电子 | 电子 | 电子 | 电子 | | | 5189 | 5318 | 8541 | 7745 | | 2 | 食品饮料 | 医药生物 | 医药生物 | 电力设备 | | | 3039 | 3195 | 4213 | 3775 | | 3 | 医药管物 | 电力设备 | 电力设备 | 通信 | | | 2892 | 2571 | 4191 | 3576 | | ব | 电力设备 | 食品饮料 | 非银金融 | 医药生物 | | | 2768 | 2533 | 2968 | 3459 | | 5 | 非银金融 1894 | 银行 2353 | 通信 2897 | 非银金融 3272 | | --- ...

AI基金东方人工智能主题混合A（005844）披露2025年四季报，第四季度基金利润163.23万元，加权平均基金份额本期利润0.0041元。报告期内，基金净值 增长率为1.22%，截至四季度末，基金规模为6亿元。 该基金属于偏股混合型基金，长期投资于TMT股票。截至1月22日，单位净值为2.026元。基金经理是严凯，目前管理的3只基金近一年均为正收益。其中， 截至1月22日，东方惠新灵活配置混合A近一年复权单位净值增长率最高，达105.58%；东方创新科技混合最低，为88.54%。 基金管理人在四季报中表示，在 AI 产业爆发式增长与国内半导体产业国产化加速推进的双重背景下，我们聚焦兼具这两大趋势的投资方向。本基金重点布 局半导体芯片产业链的短板领域，尤其关注半导体设备、材料及零组件等关键环节——这些领域不仅技术壁垒高、市场竞争优势显著，更深度受益于国家政 策扶持，具备充足的发展动力。展望未来，本基金将继续紧密跟踪半导体产业国产化进程，深度挖掘技术创新所蕴含的长期投资价值与回报机遇。 截至1月22日，东方人工智能主题混合A近三个月复权单位净值增长率为37.55%，位于同类可比基金1/229；近半年复权单位净 ...

公募基金2025年四季报披露，傅鹏博等知名基金经理2025年四季度调仓情况随之曝光。 2025年四季度，傅鹏博旗下基金前十大重仓股中，迈为股份代替中国移动新进入其前十大重仓股；增持寒武纪；减持新易盛、胜宏科技、宁德时代、腾讯控 股、东山精密、立讯精密、阿里巴巴-W、巨星科技。 | 证券代码 | 证券简称 | 持仓市值(亿元) | 持仓数量(万股) | | --- | --- | --- | --- | | 300502.SZ | 新易盛 | 20.04 | 464.98 | | 300476.SZ | 胜宏科技 | 19.77 | 693.76 | | 300750.SZ | 宁德时代 | 18.33 | 499.18 | | 0700.HK | 腾讯控股 | 18.21 | 336.58 | | 002384.SZ | 东山精密 | 16.57 | 1957.06 | | 002475.SZ | 立讯精密 | 15.41 | 2717.06 | | 300751.SZ | 迈为股份 | 12.16 | 590.22 | | 9988.HK | 阿里巴巴-W | 11.21 | 869.08 | | 6882 ...

Group 1 - The core focus is on the domestic AI industry chain, particularly the performance of the Huabao AI ETF (589520), which has shown a price increase of 0.29% and has been trading at a premium, indicating strong buying interest [1][7] - NVIDIA's CEO Jensen Huang emphasized the need for massive infrastructure investment in AI, estimating that over $1 trillion will be invested in AI-native startups by 2025, highlighting AI applications as a critical layer in the AI ecosystem [2][9] - The Ministry of Industry and Information Technology of China projected that by 2025, the number of AI companies in China will exceed 6,000, with the core industry scale expected to surpass 1.2 trillion yuan, and intelligent computing power reaching 1590 EFLOPS [3][10] Group 2 - The Huabao AI ETF's index covers four major segments: application software, terminal applications, terminal chips, and cloud chips, reflecting a shift from reliance on foreign technology to self-sufficiency in the AI industry [5][11] - The ETF's top holdings include leading domestic companies in GPUs, ASICs, and AI applications, with nearly 70% of the top ten holdings concentrated in these sectors, indicating a strong offensive strategy [12][13] - The current dynamics in the AI industry are marked by significant developments, including the launch of new policies promoting "AI + manufacturing," which is expected to drive a new wave of AI application growth [3][10]

Group 1 - In the fourth quarter of last year, 464 Sci-Tech Innovation Board stocks appeared in the fund's heavy holdings list, with 60 new additions, 193 increased holdings, and 207 reduced holdings compared to the previous quarter [1] - The total shareholding amount for these stocks reached 4.801 billion shares, with a total market value of 536.151 billion yuan at the end of the period [1] - Major stocks held by funds include SMIC, Hu Silicon Industry, and Lanke Technology, with respective holdings of 377 million shares, 295 million shares, and 268 million shares [1] Group 2 - The stocks with the highest fund holdings include Baijie Shenzhou, Baili Tianheng, and Zhongke Feicai, with fund ownership ratios of 26.20%, 25.07%, and 24.51% respectively [2] - A total of 184 stocks were held by more than 10 funds, while 80 stocks saw collective new investments from 5 to 9 funds [1][2] - The stock with the most fund holders is Cambricon, with 1,067 funds collectively holding 5.935 million shares, accounting for 14.19% of its circulating shares [1][2] Group 3 - In terms of new investments, 60 stocks were newly added, with Frontier Biotech, Baio Saitu, and New Xiangwei having the largest new holdings of 11.3733 million shares, 7.7342 million shares, and 7.1080 million shares respectively [2] - The stocks with the highest increase in holdings include Shenkong Co., Fangyuan Co., and Longda Co., with Shenkong Co. seeing a staggering increase of 59,020.96% in holdings [2] - Significant reductions were noted in stocks such as Tiejian Heavy Industry, Sikan Technology, and Electric Wind Power, with reductions of 100.00%, 99.91%, and 99.63% respectively [2]

Economic Policy - The People's Bank of China will continue to implement a moderately loose monetary policy in 2026, utilizing various tools such as reserve requirement ratio cuts and interest rate reductions to maintain ample liquidity [1] - The Ministry of Commerce and nine other departments have issued opinions to promote high-quality development in the pharmaceutical retail industry, supporting mergers and acquisitions among retail pharmacies [1] Capital Market Developments - The People's Bank of China announced a 900 billion yuan MLF operation to maintain liquidity in the banking system, with a one-year term [3] - Public funds have focused on core sectors such as electronics and power equipment, with Zhongji Xuchuang becoming the largest holding stock, valued at 78.421 billion yuan [3] - The National Development and Reform Commission has allocated 93.6 billion yuan in special bonds to support over 4,500 projects across various sectors, driving total investment exceeding 460 billion yuan [3] Industry Highlights - The commercial aerospace sector is gaining attention, with Blue Arrow Aerospace's IPO status changing to "inquiry" as it aims to become the first commercial aerospace stock [7] - Domestic AI chip company Suiyuan Technology has received approval for its IPO, aiming to raise 6 billion yuan for AI chip development [7] - The human-shaped robot sector remains active, with Zhejiang's innovation center completing a 450 million yuan Pre-A round of financing [7] Company Updates - Zhaoyi Innovation expects a net profit of 1.61 billion yuan for 2025, a year-on-year increase of approximately 46%, benefiting from AI computing demand [8] - ST Biology announced the termination of its major asset restructuring plan to acquire a 51% stake in Hunan Huize Biomedical Technology [9] - Xiaomi Group plans to repurchase up to 2.5 billion Hong Kong dollars of its Class B shares starting January 23 [10] - Alibaba has decided to support its chip subsidiary "Pingtouge" for future independent listing, initiating a restructuring process [11] - Intel reported a fourth-quarter revenue of 13.674 billion dollars, with a net loss of 591 million dollars, while its annual revenue was 52.853 billion dollars [11]

Group 1: Commercial Aerospace - The Chinese commercial aerospace sector is entering a new phase aimed at large-scale launches and commercial closed-loop systems, with significant breakthroughs expected in rocket capacity over the next 3 to 5 years [1] - By 2025, China's commercial aerospace is projected to complete 50 launches, accounting for 54% of total space launches, with 25 commercial rockets launched and 311 commercial satellites in orbit, representing 84% of total satellites [1] - The capital market for commercial aerospace companies is accelerating, with several leading firms preparing for IPOs, including Blue Arrow Aerospace and Zhongke Aerospace [1] Group 2: Public Fund Performance - The latest public fund reports reveal that the top ten holdings include companies like Zhongji Xuchuang, Ningde Times, and Tencent, with notable increases in holdings for companies like Zhongji Xuchuang, which saw an increase of 22.602 billion yuan [2] - The automotive industry is facing cost pressures due to rising prices of memory chips and metals, impacting supply chain dynamics and competition [2] Group 3: Biopharmaceutical Industry - Over 50 biopharmaceutical companies have disclosed their 2025 performance forecasts, with nearly 50% showing positive expectations, particularly in the CXO sector, where WuXi AppTec anticipates a revenue increase of approximately 15.84% [3] - The biopharmaceutical industry is expected to enter a new phase of high-quality development as structural reforms and supportive policies continue to evolve [3] Group 4: Fundraising and Market Trends - The public fund market has seen a resurgence, with several equity funds raising over 7 billion yuan, indicating a positive trend in active equity fund performance [4] - The Shanghai Suiruan Technology Co., Ltd. has received approval for its IPO, aiming to raise 6 billion yuan for product development and business expansion [5] Group 5: Aluminum Market - The aluminum market has shown strong performance, with prices rising over 12% since mid-December 2025, supported by favorable macroeconomic conditions and demand for aluminum in various applications [6] - The copper-aluminum price ratio exceeding 4 suggests a potential shift towards aluminum in sectors like air conditioning, indicating new demand growth [6] Group 6: Banking Sector - Five listed banks have reported a year-on-year increase in net profit for 2025, with improvements in non-performing loan ratios for three banks [9] - The banking sector is expected to maintain stable performance, supported by improved funding costs and a potential stabilization of net interest margins [9] Group 7: Chemical Industry - The chemical industry is experiencing positive performance, with over 60% of companies reporting improved earnings, driven by rising prices of certain chemical products [10] - The DOP market is expected to maintain upward momentum due to strong raw material prices and limited supply, indicating a stable support for pricing [10]

Core Viewpoint - The article presents a list of companies with their total market value held by funds, highlighting significant players in the market and their respective valuations in billions of yuan. Group 1: Company Market Values - Zhongji Xuchuang (300308) has a total market value of 78.42 billion yuan [1] - Xinyi Technology (300502) holds a market value of 65.70 billion yuan [1] - CATL (300750) is valued at 64.85 billion yuan [1] - Tencent Holdings (00700.HK) has a market value of 59.30 billion yuan [1] - Zijin Mining (601899) is valued at 39.31 billion yuan [1] - Alibaba Group (09988.HK) holds a market value of 31.77 billion yuan [1] - Cambricon Technologies (688256) has a market value of 29.99 billion yuan [1] - Luxshare Precision (002475) is valued at 28.70 billion yuan [1] - Kweichow Moutai (600519) holds a market value of 26.44 billion yuan [1] - Dongshan Precision (002384) is valued at 25.17 billion yuan [1]

Group 1 - The A-share market experienced fluctuations at relatively high levels in Q4 2025, with a slight decrease in overall equity positions of public funds compared to Q3 2025 [1][2] - The average equity positions for stock and mixed funds were 89.06% and 81.05%, respectively, showing a minor decline from the previous quarter [2] - Major holdings in public funds included leading light module companies, with Zhongji Xuchuang and Xinyi Sheng surpassing Ningde Times and Tencent Holdings to become the top two heavyweights [1][4] Group 2 - Several actively managed equity funds significantly increased their positions, with notable examples including Bosera Huixing and GF Chengxiang, which raised their equity positions by 12.31 and 10.3 percentage points, respectively [2] - Fund managers expressed optimism about the A-share market for 2026, citing potential dual benefits from domestic and international liquidity [3][9] - The focus on technology sectors continued, with managers identifying investment opportunities in storage chips, solid-state batteries, and humanoid robots [7][10] Group 3 - The top 50 heavyweights in public funds were primarily concentrated in information technology, consumer goods, and investment sectors, with 18 stocks in the information technology sector [4][6] - AI-related stocks gained prominence, with Zhongji Xuchuang, Xinyi Sheng, and Hanwujing entering the top seven heavyweights due to the AI boom [4][6] - The number of innovative drug companies in the top 50 heavyweights decreased from eight to five by the end of Q4 2025, indicating a shift in investment focus [5] Group 4 - Fund managers anticipate that the AI investment theme will continue to be a primary focus, with expectations for rapid growth in AI applications in the coming years [9][10] - The investment strategy is shifting towards AI applications, including smart driving, edge AI, and humanoid robots, as the industry matures [9][10] - The overall sentiment among fund managers is that the AI-driven technology market will remain a significant area of investment for the next several years [9][10]